[1] SARDI J C O, SCORZONI L, BERNARDI T, et al. Candida species:currentepidemiology, pathogenicity, biofilm formation, natural antifungal productsand new therapeutic options[J]. J Med Microbiol. 2013,62(Pt 1):10-24. [2] TALAPKO J, JUZBAŠIć M, MATIJEVIć T, et al. Candida albicans-The virulence factors and clinical manifestations of infection[J]. J Fungi,2021,7(2):79-79. [3] CHENG S C, JOOSTEN L A, KULLBERG B J, et al.Interplay between Candida albicans and the mammalian innate host defense[J]. Infect Immun,2012,80(4):1304-1313. [4] 李力翠,朱敬先,张国强,等.恶性肿瘤患者合并深部真菌感染研究进展[J].中国老年学杂志,2015,35(14):4071-4073. [5] 陈锴,鲁仁义,阎澜.白念珠菌致病因素及抗真菌药物研究进展[J].中国真菌学杂志, 2017, 12(3):180-183. [6] 买佳,王静.常用抗深部真菌感染药物及真菌对其耐药机制的研究进展[J].中国感染与化疗杂志,2015,15(4):395-398. [7] 于晓佳,周虹,崔向丽,等.注射用两性霉素B致肝损害的药学监护[J].中国临床药理学杂志, 2017,33(15):1475-1476,1490. [8] 叶健魁,王艳丽,宗峰,等.侵袭性真菌感染治疗药物研究进展[J].药学进展,2017,41(11):864-871. [9] 朱丽芳,李强.深部真菌感染研究进展[J].现代医药卫生, 2017, 33(16):2484-2487. [10] MATSUZAKI K. Control of cell selectivity of antimicrobial peptides[J]. Biochim Biophys Acta, 2009, 1788(8):1687-1692. [11] 曹小红,廖振宇,王春林,等. Bacillus natto TK-1产脂肽的纯化、抑菌活性及其表面活性剂特性[J].中国生物工程杂志,2008,28(1):44-48.[12] 程群仙,孙褔琴,吴方方,等.一株抗真菌毛霉的分离鉴定及其抗菌活性检测[J].皖南医学院学报,2016,35(3):294-296.[13] 郭娟,贠建民,邓展瑞,等.Bacillus pumilus HN-10抗菌肽P-1对粉红单端孢的抑菌机理[J].食品科,2019,40(19):17-22.[14] 蔡蜨,李心丹,邓丽莉,等.抗菌肽PAF26对采后李果实褐腐菌的抑菌效果及机理[J].食品科学,2020, 41(23):7.[15] SHIRTLIFF M E, KROM B P, MEIJERING R A M, et al. Farnesol-induced apoptosis in Candida albicans[J]. Antimicrob Agents Chemother, 2009, 53(6):2392-2401.[16] 张丹丹,刘磊,唐艳,等.昆虫抗真菌肽的作用机制与应用研究进展[J].动物医学进展,2017,37(7):74-77.[17] KOVALCHUK L V, GANKOVSKAYA L V, GANKOVSKAYA O A, et al. Herpes simplex virus:treatment with antimicrobial peptides[J]. Adv Exp Med Bio,2007,601:369-376.DOI:10.1007/978-0-387-72005-0_39. |